<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recurrent venous thrombotic and <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo>, once thought to be an uncommon entity, is increasingly being recognized </plain></SENT>
<SENT sid="1" pm="."><plain>Etiologies of recurrent <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo> usually include elements of Virchow's triad </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0277919" disease_type="Disease or Syndrome" abbrv="">Venous stasis</z:e> (e.g., immobilization, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0001513'>obesity</z:hpo>), <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> (e.g., <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>, <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>, protein C resistance, antithrombin III, protein C or S deficiency) and endothelial trauma (e.g., surgical trauma, venous trauma, in-dwelling venous instrumentation) are risk factors </plain></SENT>
<SENT sid="3" pm="."><plain>Diagnosis is dependent on objective testing, including venography duplex Doppler (color) ultrasonography and impedance plethysmography </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment is usually started with <z:chebi fb="5" ids="28304">heparin</z:chebi> or low-molecular-weight <z:chebi fb="5" ids="28304">heparin</z:chebi> and advanced to <z:chebi fb="8" ids="10033">warfarin</z:chebi> (adjusted to international normalized ratio) </plain></SENT>
<SENT sid="5" pm="."><plain>Prophylaxis may continue using low-molecular-weight <z:chebi fb="5" ids="28304">heparin</z:chebi>, <z:chebi fb="8" ids="10033">warfarin</z:chebi>, venacaval interruption (Greenfield filter), or concomitant use of the platelet-active agent indobufen and graduated compression stockings </plain></SENT>
</text></document>